This study wants to find out if a mobile app that suggests daily insulin doses is safe and works well for adults with type 2 diabetes.
Managing blood sugar is a big part of living with type 2 diabetes. Many people take long-acting insulin each day to help control their blood sugar. This study is testing a system called Smart Basal, which uses your glucose readings to suggest a daily insulin dose. The goal is to see if this system is safe and works well when used as directed. If you join the study, you will come to the clinic for at least 3 visits. At the first visit, the study team will review your health, ask questions, and complete study tests. If you are able to join, a small sensor will be placed on your arm or belly to measure your glucose levels. You will wear this sensor and use a mobile app to record your insulin doses. At home, you will keep on wearing the sensor and change it about every 15 days. The app will use your glucose levels to give daily insulin dose suggestions. You will enter your insulin doses in the app each day. You may also fill out surveys about your health, daily habits, and your experience using the sensor. At the end of the study, you will return to the clinic for an end-of-study visit. The study team will remove the device, review your health, and collect study data. Your total time in the study is about 4 months. You will be paid up to $870 if you complete all study visits and how often you use the device. If you leave the study early, you will be paid only for the visits you complete.
You may be able to join this study if you are 18 years or older and have type 2 diabetes. You must be willing to take long-acting insulin once a day, use a smartphone app, wear a glucose sensor, and record your insulin doses. You must be able to read, speak, and write in English.
Protocol Number: 26-0203
Principal Investigator